Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy

Cheng Huang(Fujian Medical University), Gang Guo(Shihezi University), Huan Hou(Sichuan University), Yunyu Feng(Sichuan University), Yi Kuang(People's Liberation Army 411 Hospital), Yuying Fu(Henan University of Technology), Yang Chen-li(Sichuan University), Yuelong Wang(Huaqiao University), Aiping Tong(Chengdu Medical College), Jianguo Xu(Sichuan University), Xiaoling Li(Southwest University), Caiying Jiang(Affiliated Hospital of Youjiang Medical University for Nationalities), Zeng Wang(Harbin Medical University), Jichao Wang(Sichuan University), Hongjian Li(Sichuan University), Wenhao Guo(Sichuan University), Zongliang Zhang(Sichuan University), Shasha Zhao(Tongji University), Hui Yang(Sichuan University), Min Mu(Sichuan University), Liangxue Zhou(University of Electronic Science and Technology of China)
Theranostics
January 1, 2020
Cited by 22


Related Papers